000106316 001__ 106316 000106316 005__ 20210727135321.0 000106316 037__ $$aTESIS-2021-232 000106316 041__ $$aeng 000106316 1001_ $$aAlboloushi,Zaid 000106316 24500 $$aMinimally invasive therapy in the treatment of plantar heel pain. 000106316 260__ $$aZaragoza$$bUniversidad de Zaragoza, Prensas de la Universidad$$c2021 000106316 300__ $$a135 000106316 4900_ $$aTesis de la Universidad de Zaragoza$$v2021-232$$x2254-7606 000106316 500__ $$aPresentado: 21 04 2021 000106316 502__ $$aTesis-Univ. Zaragoza, , 2021$$bZaragoza, Universidad de Zaragoza$$c2021 000106316 506__ $$aall-rights-reserved 000106316 520__ $$aObjectives: To compare the effectiveness of dry needling (DN) versus percutaneous needle electrolysis (PNE) for<br />improving the level of pain, function and quality of life (QoL) of patients suffering from plantar heel pain (PHP) provoked by myofascial trigger points. Design: A prospective, parallel- group, randomised controlled trial with blinded outcome assessment. Setting: A single treatment facility in the State of Kuwait. Participants: 118 participants were screened for eligibility. Of these, 102 participants were enrolled (30 men (49.5±8.9 years) and 72 women (48.1±8.8 years)) and 68 of them completed the trial. Interventions: Two parallel groups, one study arm received DN and a stretching protocol whereas the other arm received percutaneous needling electrolysis with a stretching protocol. Primary and secondary outcome measures: The primary outcome measure was the Foot Pain domain of<br />the Foot Health Status Questionnaire, with 13 questions related to foot health- related domains. Secondary outcome measures included the 0–10 numerical rating scale pain visual analogue scale (VAS) scores, performed<br />before and after each treatment session. In addition, QoL was measured using the EuroQoL-5 dimensions. All<br />measurements were taken at baseline, at 4, 8, 12, 26 and 52 weeks. Results: Foot Pain domain improved at all time points for DN group (p<0.001; 29.7 (17.8 to 41.5)) and percutaneous needling electrolysis group (p<0.001; 32.7 (18.3 to 47.0)), without significant differences between groups. Pain VAS scores decreased at all time points for both DN (p<0.001; −2.6 (−4.0 to −1.2)) and percutaneous needling electrolysis group (p<0.001; −3.0 (−4.5 to −1.6)). QoL improved at 4 weeks for both DN (p<0.01; 0.15 (0.5 to 0.25)) and percutaneous needling electrolysis group<br />(p<0.01; 0.09 (0.01 to 0.17)) and at 8 and 52 weeks for the PNE group (p<0.01; 0.10 (0.02 to 0.18)), with significant differences between groups for the QoL at 52 weeks (p<0.05; 0.10 (0.01 to 0.18)). There were two small haematomas in the PNE group and one in the DN group. No serious adverse events were reported. Conclusions: Both PNE and DN were effective for PHP management, reducing mean and maximum pain since the first treatment session, with long lasting effects (52 weeks) and significant differences between groups in the case of QoL at 52 weeks in favour of the PNE group. <br /> 000106316 520__ $$a<br /> 000106316 521__ $$97084$$aPrograma de Doctorado en Ciencias de la Salud y del Deporte 000106316 6531_ $$afisioterapia 000106316 700__ $$aHerrero Gallego, Pablo $$edir. 000106316 700__ $$aGómez Trullén, Eva M.$$edir. 000106316 7102_ $$aUniversidad de Zaragoza$$b 000106316 830__ $$9496 000106316 8560_ $$fcdeurop@unizar.es 000106316 8564_ $$s4348566$$uhttps://zaguan.unizar.es/record/106316/files/TESIS-2021-232.pdf$$zTexto completo (eng) 000106316 909CO $$ooai:zaguan.unizar.es:106316$$pdriver 000106316 909co $$ptesis 000106316 9102_ $$a$$b 000106316 980__ $$aTESIS